Navigation Links
22 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences
Date:6/13/2011

PHILADELPHIA, June 14, 2011 /PRNewswire-USNewswire/ -- Twenty-two of America's most promising scientists have been named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts.  The 2011 Pew Scholars will join a select community that includes MacArthur Fellows, recipients of the Albert Lasker Medical Research Award and three Nobel Prize winners.  Research by the new class of Scholars is related to many human diseases ranging from Alzheimer's to diabetes to ocular degeneration. The program encourages early-career scientists to advance research that leads to important medical breakthroughs and treatments.

"Pew is pleased to provide this country's most ambitious and dedicated scientists with timely funding that enables them to explore novel areas of investigation early in their careers, at what may be the most inventive and creative period in their research," said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts.

CLICK HERE TO SEE A VIDEO SHOWCASING THE WORK OF THE BIOMEDICAL SCHOLARS

To date, the program has invested more than $125 million to fund over 500 scholars. It is a rigorously competitive program where recipients receive $240,000 over four years to pursue their research without restriction. Applicants who work in all areas of physical and life sciences related to biomedical study must be nominated by an invited institution and demonstrate both excellence and innovation in their research. This year, 175 institutions were requested to nominate a candidate and 136 eligible nominations were received.

"Early recognition of young scientists with ideas that challenge their fields is essential for the vitality of the biomedical sciences," said Craig C. Mello, Ph.D., a 1995 Pew Scholar, a 2006 Nobel Laureate in Physiology or Medicine and the chair of the national advisory committee for th
'/>"/>

SOURCE The Pew Charitable Trusts
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
2. iLife Americas, LLC Enters U.S. Wellness and Therapeutic Markets
3. Americas on the Waterway Supports US Oncology Foundation
4. Cochlear Americas Provides Support for Cochlear Implant Recipients to Pursue Higher Education
5. Abbott to Present at UBS Best of Americas Investment Conference
6. Jennerex and Partners Present Positive JX-594 Randomized Phase 2 Clinical Data Showing Promising Survival Benefit in Patients with Advanced Liver Cancer
7. Ontario Institute for Cancer Research Announces Spin Off Companies Developing Promising Anticancer Technologies
8. Reportlinker Adds Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients
9. Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B
10. New findings promising for transformation optics, cloaking
11. New hydrolysis model promising tool in cellulosic biofuel studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... An analysis by Replikins, Ltd. of Pubmed ... CoV virus strains has revealed extensive conservation and ... conservation and sharing of specific Replikin gene structures has ... as it did for the H5N1 influenza vaccine and ... been found to be effective (1,2). ...
(Date:8/26/2014)... Israel , August 26, 2014 ... 3DM, supports NHS hospitals with surgery validation using its Stratasys ... - Performing surgery on 3D printed models prior to ... and provides an effective aid for both patient and surgeon ... SSYS ), a global leader of 3D printing and ...
(Date:8/26/2014)... Aug. 26, 2014 Technology Applications International ... (NUUU) has two (2) wholly- owned subsidiaries, Renuell ... harness scientifically advanced technology to provide advanced solutions ... Renuell Int,l, Inc. is launching its REJUVEL ... products that is made possible because of its ...
(Date:8/26/2014)... 2014 Trovagene, Inc. (NASDAQ:  TROV) presented ... Moving Assays to the Clinic with an ... Cell Free Tumor DNA in Urine." In this ... Precision Cancer Monitoring (PCM) platform and results from ... detection of tumor DNA mutations from urine samples ...
Breaking Biology Technology:Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... -. Actavis Group, the,international generic pharmaceuticals company, has ... Food & Drug,Administration. Distribution of the product will ... equivalent to Pfizer,s,Camptosar(R) will be available in 40 ... and is,used in the treatment of patients with ...
... CryoCath,s Cryoablation System, SAN DIEGO, Feb. 28 ... focused on the treatment of cardiac,arrhythmias, announced today ... the,United States International Trade Commission (ITC) alleging that ... by infringing on,several CryoCor patents with its cryoablation ...
... Johnson, Jr. Resigns as President and Chief Executive ... Opportunities, HAYWARD, Calif., Feb. 28 Kosan ... Robert G. Johnson, Jr.,M.D., Ph.D., has resigned as ... Kosan,s Board of Directors. Helen S. Kim, who ...
Cached Biology Technology:Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product 2CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement 2CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement 3Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 2Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 3Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 4Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 5Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 6Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 7Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 8
(Date:8/27/2014)... have found that century-old museum specimens hold clues to how ... can weaken and kill trees and the news is ... increase on oak and maple trees in warmer urban areas, ... with global warming," says Dr. Elsa Youngsteadt, a research associate ... the work. , "More scale insects would be a problem, ...
(Date:8/26/2014)... pressure from policymakers, consumers, and suppliers has prompted ... reducing the pollutants they emit from their smokestacks ... must also assess environmental performance at every step ... materials to the use and recycling of their ... the discipline known as life cycle engineering, which ...
(Date:8/26/2014)... and social problems such as global warming and ... does the burden fall on our failure as ... a new study in the Journal of ... for solving global problems from governments to consumers ... "When businesses convince politicians to encourage responsible consumption ...
Breaking Biology News(10 mins):Museum specimens, modern cities show how an insect pest will respond to climate change 2Yale journal explores advances in sustainable manufacturing 2An inconvenient truth: Does responsible consumption benefit corporations more than society? 2
... immobile organisms like plants cope when faced with alterations ... in light of new environmental conditions brought on by ... published in the Nov. 16 issue of the journal ... as their maternal plant performed almost 3 times better ...
... million-year-old dinosaur that had a mouth that worked like ... translucent skull bones will be unveiled Thursday, Nov. 15, ... Sahara by National Geographic Explorer-in-Residence Paul Sereno, paleontologist and ... a plant eater known as Nigersaurus taqueti. Originally named ...
... Cancer Foundation today announced they will collectively donate $6 ... Amplification of Research), an innovative research initiative focused on ... to treat prostate cancer, as well as other research ... the first phase of research and development with a ...
Cached Biology News:Evolutionary biology research on plant shows significance of maternal effects 2Dinosaur from Sahara ate like a 'mesozoic cow' 2Dinosaur from Sahara ate like a 'mesozoic cow' 3Safeway Inc. and PCF to fund landmark prostate cancer research collaboration 2Safeway Inc. and PCF to fund landmark prostate cancer research collaboration 3Safeway Inc. and PCF to fund landmark prostate cancer research collaboration 4
... cm, is used for vertical slab gel electrophoresis ... The cell is supplied without spacers and combs. ... gaskets, lower buffer chamber, lid with cables, 2 ... buffer dam, casting stand with gaskets, leveling bubble, ...
CleanCut agarose is used to prepare genomic DNA plugs for use in pulsed field gel electrophoresis (PFGE) applications. Supplied as a 12 ml solution of 2% agarose....
...
... This system uses the Adept CE 4100 ... CE 4200 dual wavelength detector for ... PowerStream data processing software and interface unit, CE ... Windows XP may also be used with Windows ...
Biology Products: